PULSE: the future of single-cell laboratory automation

March 05, 2025 11:47 PM AEDT | By EIN Presswire
 PULSE: the future of single-cell laboratory automation
Image source: EIN Presswire

GA, UNITED STATES, March 5, 2025 /EINPresswire.com/ -- A new technology called PULSE (Precise Ultrasonic Liquid Sample Ejection) is set to redefine the field of single-cell research. By harnessing ultrasonic waves, PULSE offers a highly precise, automated solution for conducting experiments at the single-cell level, enabling researchers to unlock new dimensions in biological studies. This innovative platform allows for the exact ejection of nanodrops containing individual cells or reagents, overcoming the limitations of traditional bulk-cell analyses. With unprecedented precision and scalability, PULSE promises to be a game changer in understanding cellular behavior, heterogeneity, and rare biological events, with far-reaching implications in medicine, tissue engineering, and synthetic biology.

While laboratory automation has revolutionized biomedical research, the challenge of performing single-cell experiments remains a significant hurdle. Traditional methods struggle to achieve the required precision and biocompatibility necessary for handling individual cells. Moreover, bulk-cell analyses often obscure valuable data due to population masking and cooperative behaviors among cells, making it difficult to obtain accurate, meaningful insights. These limitations underscore the need for new technologies capable of addressing the complexities of single-cell experimentation with minimal interference.

In a study (DOI: 10.1038/s41378-024-00798-y) published on August 17, 2024, in Microsystems & Nanoengineering, researchers from Duke University introduced PULSE as a novel solution to the limitations of current single-cell research methodologies. This breakthrough technology facilitates the precise deposition of single cells and reagents into nanodrop arrays, making it possible to conduct high-resolution biological experiments with remarkable accuracy and scalability.

PULSE represents a significant leap forward in single-cell research. The platform enables the controlled deposition of single cells and reagents into nanodrop arrays, with volumes ranging from picoliters to microliters. Ultrasonic waves ensure a high degree of precision (90.5-97.7% accuracy) and speed (5-20 cells per second), surpassing traditional pipetting robots. PULSE's ability to handle delicate biological samples without compromising cell integrity or viability is a key advantage, allowing for more reliable and reproducible results in sensitive experiments.

The PULSE technology is versatile, supporting multiple functionalities such as biofabrication, precision gating, and deterministic array barcoding. In biofabrication, PULSE can create complex hybrid spheroids and hydrogel patterns by precisely depositing different cell types. The precision gating function allows researchers to isolate and observe individual cells, revealing heterogeneity and rare biological events within populations. Additionally, the deterministic array barcoding technique links cell behavior with genetic data, offering a direct correlation between phenotypic and genotypic information. This ability to analyze single-cell phenotypes alongside genetic data opens new avenues for comprehensive, high-resolution research.

According to Dr. Tony Jun Huang, a leading researcher on the project, "This technology represents a major leap forward in single-cell research. By enabling precise and dynamic analyses at the single-cell level, PULSE provides researchers with a powerful tool to explore complex biological systems with unprecedented resolution and accuracy."

The potential applications of PULSE span a wide range of fields. In embryogenesis, the technology can provide unprecedented control over cell development and differentiation. In tissue engineering, it facilitates the creation of intricate cellular structures with unmatched precision. PULSE also holds great promise for immunology, enabling detailed analysis of immune cell behavior and interactions. In drug screening, the platform allows for targeted drug delivery to individual cells, uncovering unique responses and resistance mechanisms. By automating single-cell experiments, PULSE enhances both the efficiency and accuracy of research, driving innovations in personalized medicine and advanced biotechnological applications. Its ability to preserve cell integrity positions it as an essential tool for precision medicine and synthetic biology, marking the dawn of a new era in cellular research.

DOI
10.1038/s41378-024-00798-y

Original Source URL
https://doi.org/10.1038/s41378-024-00798-y

Funding information
We acknowledge support from the National Institutes of Health (Grant numbers: R01HD103727, UH3TR002978, R01GM141055, R44OD024963, R44HL140800, and R44AG063643).

Lucy Wang
BioDesign Research
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.